{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:57:48Z","timestamp":1792612668150,"version":"4.5.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2023.1209625","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T04:55:41Z","timestamp":1684731341000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Editorial: The heart of NAFLD"],"prefix":"10.3389","volume":"10","author":[{"given":"Nicholas W. S.","family":"Chew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiphan","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"155402","DOI":"10.1016\/j.metabol.2023.155402","article-title":"The global syndemic of metabolic diseases in the young adult population: a consortium of trends and projections from the Global Burden of Disease 2000-2019","volume":"141","author":"Chong","year":"2023","journal-title":"Metab Clin Exp."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e009340","DOI":"10.1161\/CIRCOUTCOMES.122.009340","article-title":"Long-term prognosis of patients with coexisting obesity and malnutrition after acute myocardial infarction: a cohort study","volume":"16","author":"Kong","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"B3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The global burden of metabolic disease: data from 2000 to 2019","volume":"35","author":"Chew","year":"2023","journal-title":"Cell Metab."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2022.11.006","article-title":"Hepatic, extra-hepatic outcomes and causes of mortality in NAFLD \u2013 an umbrella overview of systematic review of meta-analysis","author":"Xiao","year":"2022","journal-title":"J Clin Exp Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.eprac.2022.10.007","article-title":"A meta-analysis on associated risk of mortality in nonalcoholic fatty liver disease","volume":"29","author":"Fu","year":"2023","journal-title":"Endocr Pract."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.06.029","article-title":"Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD - a systematic review and meta-analysis","author":"Tang","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"9935","DOI":"10.3390\/ijerph19169935","article-title":"Historical changes in weight classes and the influence of NAFLD prevalence: a population analysis of 34,486 individuals","volume":"19","author":"Nah","year":"2022","journal-title":"Int J Environ Res Public Health."},{"key":"B8","doi-asserted-by":"publisher","first-page":"101685","DOI":"10.1016\/j.eclinm.2022.101685","article-title":"The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis","volume":"54","author":"Chin","year":"2022","journal-title":"EClinicalMedicine."},{"key":"B9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.eprac.2022.10.006","article-title":"Barriers and facilitators to engagement with a weight management intervention in asian patients with overweight or obesity: a systematic review","volume":"29","author":"Anand","year":"2022","journal-title":"Endocr Pract."},{"key":"B10","doi-asserted-by":"publisher","first-page":"101850","DOI":"10.1016\/j.eclinm.2023.101850","article-title":"Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019","volume":"57","author":"Chong","year":"2023","journal-title":"EClinicalMedicine."},{"key":"B11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/oby.23600","article-title":"The efficacy of GLP-1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review","volume":"31","author":"Llewellyn","year":"2023","journal-title":"Obesity."},{"key":"B12","doi-asserted-by":"publisher","first-page":"942753","DOI":"10.3389\/fcvm.2022.942753","article-title":"Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality","volume":"9","author":"Ng","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3350\/cmh.2022.0096","article-title":"The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease","volume":"28","author":"Ng","year":"2022","journal-title":"Clin Mol Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/oby.23658","article-title":"A two-decade population-based study on the effect of hypertension in the general population with obesity in the United States","volume":"31","author":"Kong","year":"2023","journal-title":"Obesity."},{"key":"B15","doi-asserted-by":"publisher","first-page":"971484","DOI":"10.3389\/fgene.2022.971484","article-title":"The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases","volume":"13","author":"Chew","year":"2022","journal-title":"Front Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.cgh.2021.09.021","article-title":"A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease","volume":"20","author":"Toh","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ijcard.2022.09.062","article-title":"Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: results from a global meta-analysis of 1,285,722 patients","volume":"371","author":"Kong","year":"2023","journal-title":"Int J Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3350\/cmh.2021.0406","article-title":"Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: an updated meta-analysis with 135,602 individuals","volume":"28","author":"Tang","year":"2022","journal-title":"Clin Mol Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.eprac.2022.03.016","article-title":"Metabolic associated fatty liver disease increases the risk of systemic complications and mortality. a meta-analysis and systematic review of 12 620 736 individuals","volume":"28","author":"Quek","year":"2022","journal-title":"Endocr Pract."},{"key":"B20","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.eprac.2022.05.007","article-title":"Long-term prognosis of acute myocardial infarction associated with metabolic health and obesity status","volume":"28","author":"Chew","year":"2022","journal-title":"Endocr Pract."},{"key":"B21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11239-022-02704-7","article-title":"Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study Of 5400 asian patients","volume":"54","author":"Kong","year":"2022","journal-title":"J Thromb Thrombol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/dom.14950","article-title":"Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction","volume":"25","author":"Chin","year":"2023","journal-title":"Diabetes Obes Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12072-022-10319-6","article-title":"Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis","volume":"16","author":"Yong","year":"2022","journal-title":"Hepatol Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e14793","DOI":"10.1111\/ctr.14793","article-title":"Echocardiographic assessment of cardiovascular function and clinical outcomes in liver transplant recipients","volume":"36","author":"Lim","year":"2022","journal-title":"Clin Transplant."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1111\/dom.14820","article-title":"Hepatic steatosis and advanced fibrosis are independent predictors of mortality in acute myocardial infarction without standard modifiable risk factors","volume":"24","author":"Chew","year":"2022","journal-title":"Diabetes Obes Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/apt.17397","article-title":"Original article: the prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndrome","volume":"57","author":"Fu","year":"2023","journal-title":"Aliment Pharmacol Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.cjca.2022.07.016","article-title":"FIB-4 Predicts MACE and cardiovascular mortality in patients with nonalcoholic fatty liver disease","volume":"38","author":"Chew","year":"2022","journal-title":"Can J Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.cgh.2021.11.038","article-title":"An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD","volume":"21","author":"Lim","year":"2023","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals","volume":"107","author":"Chan","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.09.028","article-title":"The spectrum and impact of metabolic dysfunction in MAFLD: a longitudinal cohort analysis of 32,683 overweight and obese individuals","author":"Chan","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1097\/HEP.0000000000000043","article-title":"Examining the interim proposal for name change to steatotic liver disease in the US population","volume":"77","author":"Ng","year":"2023","journal-title":"Hepatology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/oby.23453","article-title":"Comparison of mechanistic pathways of bariatric surgery in patients with diabetes mellitus: a Bayesian network meta-analysis","volume":"30","author":"Lin","year":"2022","journal-title":"Obesity."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/apt.16808","article-title":"Meta-analysis: analysis of mechanistic pathways in the treatment of non-alcoholic steatohepatitis. Evidence from a Bayesian network meta-analysis","volume":"55","author":"Ng","year":"2022","journal-title":"Aliment Pharmacol Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/a-1877-9656","article-title":"Nonalcoholic steatohepatitis drug development pipeline: an update","volume":"42","author":"Chew","year":"2022","journal-title":"Semin Liver Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/ehf2.13822","article-title":"Can glucose-lowering medications improve outcomes in non-diabetic heart failure patients? A Bayesian network meta-analysis","volume":"9","author":"Yeong","year":"2022","journal-title":"ESC Heart Fail."},{"key":"B36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.eprac.2021.09.013","article-title":"Antidiabetic medications for type 2 diabetics with nonalcoholic fatty liver disease: evidence from a network meta-analysis of randomized controlled trials","volume":"28","author":"Ng","year":"2022","journal-title":"Endocr Pract."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/hep.32315","article-title":"Placebo effect on progression and regression in NASH: evidence from a meta-analysis","volume":"75","author":"Ng","year":"2022","journal-title":"Hepatology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"756810","DOI":"10.3389\/fcvm.2021.756810","article-title":"The association of plant-based diet with cardiovascular disease and mortality: a meta-analysis and systematic review of prospect cohort studies","volume":"8","author":"Quek","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11883-022-01027-5","article-title":"comprehensive review and updates on holistic approach towards non-alcoholic fatty liver disease management with cardiovascular disease","volume":"24","author":"Chew","year":"2022","journal-title":"Curr Atheroscler Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/apt.17121","article-title":"Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives","volume":"56","author":"Ng","year":"2022","journal-title":"Aliment Pharmacol Ther."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcac060","article-title":"Meta-analysis of the placebo and nocebo effects associated with placebo treatment in randomized trials of lipid lowering therapy","author":"Chin","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes."},{"key":"B42","doi-asserted-by":"publisher","first-page":"645","DOI":"10.14309\/ajg.0000000000002042","article-title":"Placebo adverse events in non-alcoholic steatohepatitis clinical trials: a pooled analysis of 2,944 participants","volume":"118","author":"Tay","year":"2022","journal-title":"Am J Gastroenterol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn-21-520","article-title":"Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals","author":"Lim","year":"2022","journal-title":"Hepatobil Surg Nutr."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1209625\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T04:55:43Z","timestamp":1684731343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1209625\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":43,"alternative-id":["10.3389\/fmed.2023.1209625"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1209625","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"article-number":"1209625"}}